General Updates

NAVA LIMITED NAVA/SECTL/88/2026-27 June 22, 2026 Listing Department Dept. of Corp. Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street Bandra Kurla Complex, Bandra (E) MUMBAI – 400 001 MUMBAI – 400 051 NSE Symbol: ‘NAVA’ Scrip Code: ‘513023’ / ‘NAVA Dear Sir/ Madam, Sub: Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”). --o0o-- This is to inform you that the Board of Directors of the Company, at its meeting held today, i.e., June 22, 2026, has, inter alia, considered and approved the proposed amalgamation of Nava Healthcare Pte. Ltd., a wholly owned subsidiary of the Company, with Nava Global Pte. Ltd., another wholly owned subsidiary of the Company, subject to the requisite approvals from the relevant regulatory authorities and compliance with the applicable laws of Singapore. The amalgamation is proposed as part of an internal reorganization of the Company's subsidiary structure and is subject to such terms and conditions as may be prescribed by the relevant regulations and authorities. Details as required under SEBI circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are annexed herewith This document is made available on the website of the Company at https://www.navalimited.com/investors/stock-exchange-disclosures/disclosures/ Kindly take the same on record and acknowledge the receipt. Thanking You, Yours faithfully, for NAVA LIMITED VSN Raju Company Secretary & Vice President Encl: as above Regd. Off.: Nava Bharat Chambers, 6-3-1109/1, 3rd Floor, Raj Bhavan Road, Somajiguda, Hyderabad - 500 082, Telangana, India. CIN: L27101TG1972PLC001549 T +91 40 40345999, +91 40 23403501 E nava@navalimited.com; investorservices@navalimited.com W www.navalimited.com ISO 9001 | ISO 14001 | ISO 45001 | ISO 50001 NAVA LIMITED ANNEXURE - 1 Amalgamation/ Merger: a) Name of the entity(ies) forming part Nava Global Pte. Ltd (Reg. no. 200409999D) (NGPL) and of the amalgamation/merger, details Nava Healthcare Pte. Ltd (Reg. no. 201726052H) (NHPL) in brief such as, size, turnover etc.; are investment holding companies of Nava (as per financials set out below), operating in Singapore. As at 31.03.2026 Financial data NGPL NHPL Income Rs. 1,05,914 lakhs Rs. 279 lakhs US$ 120 mn US$ 0.3 mn Networth Rs. 2,72,988 lakhs Rs. 7,468 lakhs (US$ 288.4 mn) (US$ 7.9 mn) b) Whether the transaction would fall Yes, the transaction is a related party transaction and is within related party transactions? If between the two wholly owned subsidiaries (in Singapore) yes, whether the same is done at of the Company. NHPL is proposed to be amalgamated into “arm’s length” NGPL in compliance with applicable laws. c) Area of business of the entity(ies) NGPL holds downstream investments in Energy, Mining and Metals while NHPL holds downstream investments in healthcare trading and services. d) Rationale for amalgamation/ merger NGPL has established investments across the energy, minerals and metals sectors and plans to further diversify its investment portfolio across businesses and geographies, leveraging its long-standing presence in the APAC region. NHPL, through its subsidiaries in Singapore and Malaysia, has investments in the trading of niche women's healthcare and lifestyle improvement products. Healthcare business, hitherto pursued by NHPL attained certain traction in Malaysia and Singapore, further growth of which is however incumbent upon focused approach and other value-added offerings which will ensure sustained positive cash flows. This requires strategic partnership with experienced professional concerns to target potential upsides. Accordingly, NGPL, post amalgamation of NHPL, will pursue a strategic business restructuring including joint ventures to bring in other medical offerings, aside from continuing the existing trading business of the niche products in South East Asia. This is expected to ensure continuity of the existing business, facilitate expansion into value-added healthcare services and other growth opportunities for which potential exists in South East Asia. NGPL, will continue to Regd. Off.: Nava Bharat Chambers, 6-3-1109/1, 3rd Floor, Raj Bhavan Road, Somajiguda, Hyderabad - 500 082, Telangana, India. CIN: L27101TG1972PLC001549 T +91 40 40345999, +91 40 23403501 E nava@navalimited.com; investorservices@navalimited.com W www.navalimited.com ISO 9001 | ISO 14001 | ISO 45001 | ISO 50001 NAVA LIMITED be vigilant to emerging opportunities in South East Asia in this sector. The proposed amalgamation of NHPL with NGPL will consolidate the Group's investments (other than commercial agriculture and O&M services) under one platform. NGPL will oversee the restructured healthcare investment under a simplified holding structure, as part of the Group's broader investment diversification in the pursuit of long-term value for stakeholders. e) In case of cash consideration – Since both the Companies involved in amalgamation are amount or otherwise share exchange wholly owned subsidiaries of Nava Limited, Nava’s holding ratio in NHPL will be cancelled and, NGPL issues new shares to Nava after amalgamation. f) Brief details of change in The proposed amalgamation is between two wholly owned shareholding pattern (if any) of subsidiaries of the Company and, therefore, will not result in listed entity any change in the shareholding pattern of the Company. Regd. Off.: Nava Bharat Chambers, 6-3-1109/1, 3rd Floor, Raj Bhavan Road, Somajiguda, Hyderabad - 500 082, Telangana, India. CIN: L27101TG1972PLC001549 T +91 40 40345999, +91 40 23403501 E nava@navalimited.com; investorservices@navalimited.com W www.navalimited.com ISO 9001 | ISO 14001 | ISO 45001 | ISO 50001